| Methods used to evaluate pain behaviors in rodents JR Deuis, LS Dvorakova, I Vetter Frontiers in molecular neuroscience 10, 284, 2017 | 1175 | 2017 |
| An animal model of oxaliplatin-induced cold allodynia reveals a crucial role for Nav1. 6 in peripheral pain pathways JR Deuis, K Zimmermann, AA Romanovsky, LD Possani, PJ Cabot, ... Pain® 154 (9), 1749-1757, 2013 | 207 | 2013 |
| Pharmacological characterisation of the highly NaV1.7 selective spider venom peptide Pn3a JR Deuis, Z Dekan, JS Wingerd, JJ Smith, NR Munasinghe, RF Bhola, ... Scientific reports 7 (1), 40883, 2017 | 150 | 2017 |
| NaV1. 7 as a pain target–from gene to pharmacology I Vetter, JR Deuis, A Mueller, MR Israel, H Starobova, A Zhang, LD Rash, ... Pharmacology & therapeutics 172, 73-100, 2017 | 146 | 2017 |
| Burn pain: a systematic and critical review of epidemiology, pathophysiology, and treatment M Morgan, JR Deuis, M Frøsig-Jørgensen, RJ Lewis, PJ Cabot, PD Gray, ... Pain medicine 19 (4), 708-734, 2018 | 129 | 2018 |
| Analgesic Effects of GpTx-1, PF-04856264 and CNV1014802 in a Mouse Model of NaV1.7-Mediated Pain JR Deuis, JS Wingerd, Z Winter, T Durek, Z Dekan, SR Sousa, ... Toxins 8 (3), 78, 2016 | 120 | 2016 |
| Identification and characterization of ProTx-III [μ-TRTX-Tp1a], a new voltage-gated sodium channel inhibitor from venom of the tarantula Thrixopelma pruriens FC Cardoso, Z Dekan, KJ Rosengren, A Erickson, I Vetter, JR Deuis, ... Molecular pharmacology 88 (2), 291-303, 2015 | 95 | 2015 |
| Multiple sodium channel isoforms mediate the pathological effects of Pacific ciguatoxin-1 MC Inserra, MR Israel, A Caldwell, J Castro, JR Deuis, AM Harrington, ... Scientific reports 7 (1), 42810, 2017 | 84 | 2017 |
| The pharmacology of voltage-gated sodium channel activators JR Deuis, A Mueller, MR Israel, I Vetter Neuropharmacology 127, 87-108, 2017 | 80 | 2017 |
| Sodium channels and venom peptide pharmacology MR Israel, B Tay, JR Deuis, I Vetter Advances in pharmacology 79, 67-116, 2017 | 75 | 2017 |
| The thermal probe test: A novel behavioral assay to quantify thermal paw withdrawal thresholds in mice JR Deuis, I Vetter Temperature 3 (2), 199-207, 2016 | 75 | 2016 |
| The snake with the scorpion’s sting: Novel three-finger toxin sodium channel activators from the venom of the long-glanded blue coral snake (Calliophis bivirgatus) DC Yang, JR Deuis, D Dashevsky, J Dobson, TNW Jackson, A Brust, ... Toxins 8 (10), 303, 2016 | 73 | 2016 |
| Transcriptomic and behavioural characterisation of a mouse model of burn pain identify the cholecystokinin 2 receptor as an analgesic target K Yin, JR Deuis, RJ Lewis, I Vetter Molecular pain 12, 1744806916665366, 2016 | 72 | 2016 |
| Analgesic treatment of ciguatoxin-induced cold allodynia K Zimmermann, JR Deuis, MC Inserra, LS Collins, B Namer, PJ Cabot, ... Pain 154 (10), 1999-2006, 2013 | 63 | 2013 |
| Analgesic effects of clinically used compounds in novel mouse models of polyneuropathy induced by oxaliplatin and cisplatin JR Deuis, YL Lim, S Rodrigues de Sousa, RJ Lewis, PF Alewood, ... Neuro-oncology 16 (10), 1324-1332, 2014 | 57 | 2014 |
| Antiallodynic effects of the selective NaV1. 7 inhibitor Pn3a in a mouse model of acute postsurgical pain: evidence for analgesic synergy with opioids and baclofen A Mueller, H Starobova, M Morgan, Z Dekan, O Cheneval, CI Schroeder, ... Pain 160 (8), 1766-1780, 2019 | 56 | 2019 |
| Modulatory features of the novel spider toxin μ‐TRTX‐Df1a isolated from the venom of the spider Davus fasciatus FC Cardoso, Z Dekan, JJ Smith, JR Deuis, I Vetter, V Herzig, PF Alewood, ... British journal of pharmacology 174 (15), 2528-2544, 2017 | 53 | 2017 |
| Inflammatory and neuropathic gene expression signatures of chemotherapy-induced neuropathy induced by vincristine, cisplatin, and oxaliplatin in C57BL/6J mice H Starobova, A Mueller, JR Deuis, DA Carter, I Vetter The journal of pain 21 (1-2), 182-194, 2020 | 49 | 2020 |
| The structure, dynamics and selectivity profile of a NaV1.7 potency-optimised huwentoxin-IV variant S Rahnama, JR Deuis, FC Cardoso, V Ramanujam, RJ Lewis, LD Rash, ... PLoS one 12 (3), e0173551, 2017 | 46 | 2017 |
| Vincristine-induced peripheral neuropathy is driven by canonical NLRP3 activation and IL-1β release H Starobova, M Monteleone, C Adolphe, L Batoon, CJ Sandrock, B Tay, ... Journal of Experimental Medicine 218 (5), 2021 | 45 | 2021 |
Irina VetterUniversity of Queenslanduq.edu.au üzerinde doğrulanmış e-posta adresine sahip